These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14635470)

  • 1. The optimal immunotherapy cluster schedule in clinical practice.
    Fernández-Távora L; Moreno C; Martín S; Rico P
    J Investig Allergol Clin Immunol; 2003; 13(3):193-201. PubMed ID: 14635470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible approaches in the design of subcutaneous immunotherapy protocols for Hymenoptera venom allergy.
    Alessandrini AE; Berra D; Rizzini FL; Mauro M; Melchiorre A; Rossi F; Spezia D; Stanizzi R; Ricciardi L; Burastero SE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):92-7. PubMed ID: 16892788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
    Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
    J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
    Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
    Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated immunotherapy schedules: review of efficacy and safety.
    Cox L
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):126-37; quiz 137-40, 202. PubMed ID: 16937741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.
    Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA
    Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of cluster specific immunotherapy with a modified high-dose house dust mite extract.
    Nieto García A; Nevot Falcó S; Carrillo Díaz T; Cumplido Bonny JA; Izquierdo Calderón JP; Hernández-Peña J
    Eur Ann Allergy Clin Immunol; 2013 May; 45(3):78-83. PubMed ID: 23862396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective safety study of immunotherapy administered in a cluster schedule.
    Serrano P; Algorta J; Martínez A; González-Quevedo T; Velázquez E; Díaz M
    J Investig Allergol Clin Immunol; 2004; 14(4):312-9. PubMed ID: 15736717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustered schedules in allergen-specific immunotherapy.
    Parmiani S; Fernández Távora L; Moreno C; Guardia P; Rico P
    Allergol Immunopathol (Madr); 2002; 30(5):283-91. PubMed ID: 12396963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study.
    Tabar AI; Fernández-Távora L; Alonso R; Castillo R; Cisteró-Bahima A; de la Torre-Morin F; Fernández J; García-Figueroa BE; Fernández S; García-González JJ; García-Robaina JC; Moreno F; Lobatón P; Sánchez-Machín I; de la Torre-Martínez F
    J Investig Allergol Clin Immunol; 2004; 14(3):193-7. PubMed ID: 15552712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster protocols in SCIT: enough evidence for practical use?
    Pfaar O; Leitzbach S; Hörmann K; Klimek L
    Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):188-93. PubMed ID: 20410818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
    Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
    Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
    Kelso JM
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher frequency of early local side effects with aqueous versus depot immunotherapy for hymenoptera venom allergy.
    Cadario G; Marengo F; Ranghino E; Rossi R; Gatti B; Cantone R; Bona F; Pellegrino R; Feyles G; Puccinelli P; Burastero SE
    J Investig Allergol Clin Immunol; 2004; 14(2):127-33. PubMed ID: 15301302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts.
    Portnoy J; Bagstad K; Kanarek H; Pacheco F; Hall B; Barnes C
    Ann Allergy; 1994 Nov; 73(5):409-18. PubMed ID: 7978533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated immunotherapy schedules and premedication.
    Calabria CW; Cox L
    Immunol Allergy Clin North Am; 2011 May; 31(2):251-63, ix. PubMed ID: 21530818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.